Perspective: Genetic causes of human reproductive disease

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2447-2454

  Achermann, John C ^a   Ozisik, Gokhan ^b   Meeks, Joshua J ^a   Larry Jameson, J ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADORELIN; GONADORELIN RECEPTOR; GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

CLINICAL FEATURE; GAMETOGENESIS; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GONAD DEVELOPMENT; GONADORELIN RELEASE; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INFERTILITY; INHERITANCE; KALLMANN SYNDROME; KNOCKOUT GENE; MUTAGENESIS; OBESITY; OVARY DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SPERMATOGENESIS; GENETICS; MUTATION;

HUMANS; INFERTILITY; MUTATION;

EID: 0036598227     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.6.2447     Document Type: Review

References (60)

1. Infertility and fertility control
2. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules
3. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules
4. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): Pathophysiological and genetic considerations
5. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: Implications for the developmental anomalies of X chromosome-linked Kallmann syndrome
6. The importance of autosomal genes in Kallmann syndrome: Genotype-phenotype correlations and neuroendocrine characteristics
7. A leptin missense mutation associated with hypogonadism and morbid obesity
8. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
9. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
10. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
11. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor
12. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism
13. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism
14. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration
15. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations
16. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse
17. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia
18. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency
19. Mutations in PROP1 cause familial combined pituitary hormone deficiency
20. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg->Cys at codon 120 (R120C)
21. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
22. Primary amenorrhoea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone
23. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene
24. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
25. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor
26. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility
27. Male hypogonadism due to a mutation in the gene for the β-subunit of follicle-stimulating hormone
28. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone
29. Brief report: Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene
30. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor
31. The genetics and biology of vertebrate sex determination
32. The genetics of male undermasculinization
33. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
34. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans
35. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions
36. Androgen-insensitivity syndrome as a possible coactivator disease
37. Estrogen and spermatogenesis
38. Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism
39. Y chromosome microdeletions and alterations in spermatogenesis
40. An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y
41. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry
42. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia
43. Inhibin: A candidate gene for premature ovarian failure
44. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
45. Steroidogenic factor 1: A key determinant of endocrine development and function
46. A mutation in the gene encoding steroidogenic factor-1 causes XY sex-reversal and adrenal failure in humans
47. A naturally-occurring steroidogenic factor-1 (SF-1) mutation exhibits differential binding and activation of target genes
48. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner
49. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency
50. Mutations in NR0B1 (DAX1) and NR5A (SF1) responsible for adrenal hypoplasia congenita
51. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production
52. X-linked adrenal hypoplasia congenita: A mutation in DAX1 expands the phenotypic spectrum in males and females
53. A novel mutation in DAX1 causes delayed onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism
54. Missense mutations cluster within the carboxyl-terminal region of DAX1 and impair transcriptional repression
55. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene
56. Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay
57. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita
58. Vulnerability within a robust complex system. DAX-1 mutations and steroidogenic axis development